Suppr超能文献

细胞辅助脂肪移植治疗难治性脓毒症相关性肛瘘:一项初步研究

Cell-assisted lipotransfer in treating uncontrollable sepsis associated perianal fistula: a pilot study.

作者信息

Jeong In Seob, Hwang Sung Hwan, Yu Hye Mi, Jeong Hyeonseok

机构信息

Department of Surgery, Busan Hangun Hospital, Busan, Korea.

Department of Surgery, Hangun Hospital Bumcheon Campus, Busan, Korea.

出版信息

Ann Coloproctol. 2024 Apr;40(2):169-175. doi: 10.3393/ac.2022.00486.0069. Epub 2023 Feb 6.

Abstract

PURPOSE

Surgeons can treat debilitating conditions of uncontrollable complex anorectal fistulas with sepsis, even after repeated fistula surgeries, for curative intention. Adipose-derived stem cells have shown good outcomes for refractory Crohn fistula. Unfortunately, cell therapy has some limitations, including high costs. We have therefore attempted immediate cell-assisted lipotransfer (CAL) in treating refractory complex anal fistulas and observed its outcomes.

METHODS

In a retrospective study, CAL, using a mixture of freshly extracted autologous stromal vascular fraction (SVF) and fat tissues, was used to treat 22 patients of refractory complex anal fistula from March 2018 to May 2021. Preoperative and postoperative assessments were performed with direct visual inspection, digital palpation, and endoanal ultrasonography. A fistula was considered completely healed if (1) the patient had no symptoms of discharge or inflammation; (2) there were no visible secondary openings of fistula tract inside and outside of the anorectal unit and even in the perineum; and (3) there was no primary opening in the anus. The endpoint of complete remission was wound healing without signs of inflammation 3 months after CAL treatment.

RESULTS

In a total of 22 patients who received CAL treatment, 19 patients showed complete remission, 1 patient showed partial improvement, and 2 patients showed no improvement. One of the 2 patients without improvement at primary endpoint showed complete remission 9 months after CAL. There were no significant adverse effects of the procedure.

CONCLUSION

We found that the immediately-collected CAL procedure for refractory complex anal fistula showed good outcomes without adverse side effects. It can be strongly recommended as an alternative surgical option for the treatment of complex anal fistula that is uncontrollable even after repeated surgical procedures. However, considering the unpredictable characteristics of SVF, long-term follow-up is necessary.

摘要

目的

对于患有脓毒症的无法控制的复杂性肛肠瘘,即使在多次瘘管手术后,外科医生也可出于治愈目的进行治疗。脂肪来源干细胞已显示出对难治性克罗恩瘘有良好疗效。不幸的是,细胞疗法存在一些局限性,包括成本高昂。因此,我们尝试采用即时细胞辅助脂肪移植(CAL)来治疗难治性复杂性肛瘘,并观察其疗效。

方法

在一项回顾性研究中,2018年3月至2021年5月期间,使用新鲜提取的自体基质血管成分(SVF)和脂肪组织的混合物进行CAL,治疗22例难治性复杂性肛瘘患者。术前和术后通过直接目视检查、指诊和肛门内超声进行评估。如果满足以下条件,则认为瘘管完全愈合:(1)患者无排出或炎症症状;(2)肛肠单位内外甚至会阴处均无可见的瘘管继发开口;(3)肛门无原发开口。完全缓解的终点是CAL治疗后3个月伤口愈合且无炎症迹象。

结果

在总共22例接受CAL治疗的患者中,19例完全缓解,1例部分改善,2例无改善。在主要终点未改善的2例患者中,有1例在CAL治疗9个月后完全缓解。该手术无明显不良反应。

结论

我们发现,用于难治性复杂性肛瘘的即时采集CAL手术显示出良好疗效且无不良副作用。对于即使经过多次手术仍无法控制的复杂性肛瘘,强烈推荐将其作为一种替代手术选择。然而,考虑到SVF的不可预测特性,有必要进行长期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5464/11082549/ba415012cdab/ac-2022-00486-0069f1.jpg

相似文献

引用本文的文献

1
Tissue engineering and regenerative medicine approaches in colorectal surgery.结直肠手术中的组织工程与再生医学方法
Ann Coloproctol. 2024 Aug;40(4):336-349. doi: 10.3393/ac.2024.00437.0062. Epub 2024 Aug 30.

本文引用的文献

3
Recurrent anal fistulas: When, why, and how to manage?复发性肛瘘:何时、为何以及如何处理?
World J Clin Cases. 2020 May 6;8(9):1586-1591. doi: 10.12998/wjcc.v8.i9.1586.
5
Effectiveness of Autologous Fat Graft in Treating Fecal Incontinence.自体脂肪移植治疗大便失禁的有效性
Ann Coloproctol. 2019 Jun;35(3):144-151. doi: 10.3393/ac.2018.09.15. Epub 2019 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验